HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens.

In Part 1 of this Spotlight special briefing, we looked at some of the big picture dynamics of HIV in South Africa. Most of ...

With 85% 10-year survival reported in HIV-positive transplant recipients in Spain, the country is now moving toward policy ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

A medical doctor, Dr Iyayi Osifo, has sparked interest in a rare genetic mutation that gives some individuals resistance to ...

A paper published in Nature Communications says that scientists at the Peter Doherty Institute for Infection and Immunity in ...

The Philippines is currently facing a sharp rise in HIV cases, with a staggering 500% increase reported among the youth.

Updated CDC guidelines on PEP after nonoccupational HIV exposure address newer ART agents and clinical considerations for patients with a history of long-acting ART.

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...

“Despite nearly four decades of effort by the global research community, an effective vaccine to prevent HIV remains an ...